Strategies to Prevent or Remediate Cancer and Treatment-Related Aging
Open Access
- 29 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 113 (2), 112-122
- https://doi.org/10.1093/jnci/djaa060
Abstract
Up to 85% of adult cancer survivors and 99% of adult survivors of childhood cancer live with an accumulation of chronic conditions, frailty, and/or cognitive impairments resulting from cancer and its treatment. Thus, survivors often show an accelerated development of multiple geriatric syndromes and need therapeutic interventions. To advance progress in this area, the National Cancer Institute convened the second of 2 think tanks under the auspices of the Cancer and Accelerated Aging: Advancing Research for Healthy Survivors initiative. Experts assembled to share evidence of promising strategies to prevent, slow, or reverse the aging consequences of cancer and its treatment. The meeting identified research and resource needs, including geroscience-guided clinical trials; comprehensive assessments of functional, cognitive, and psychosocial vulnerabilities to assess and predict age-related outcomes; preclinical and clinical research to determine the optimal dosing for behavioral (eg, diet, exercise) and pharmacologic (eg, senolytic) therapies; health-care delivery research to evaluate the efficacy of integrated cancer care delivery models; optimization of intervention implementation, delivery, and uptake; and patient and provider education on cancer and treatment-related late and long-term adverse effects. Addressing these needs will expand knowledge of aging-related consequences of cancer and cancer treatment and inform strategies to promote healthy aging of cancer survivors.Keywords
Funding Information
- National Institutes of Health (R01CA172119, R01CA129769, U54CA137788, R01CA218496, R01CA129769, P30CA008748)
- TAA (R21/R33AG059206)
- WD (DP2CA195765, R01CA231014)
- MCJ (R37AG013925, R33AG061456)
- JLK (P01AG062413)
- JLK
- LJN (P30AG021334, U01AG020478, U01AG020487, U01AG020480)
- SNM (K24AG056589)
- SGM (AG043376, AG056278)
- LJN (R21CA218732)
- KS (R21AG053198, U01AG057545)
- JAS (P30CA008748)
- JMS (R01AG052964)
- RT (USDA, # 58–1950-0–014, 58–805-9–004)
- American Cancer Society (CRP 14–111-01-CPPB)
- AKTIV Against Cancer
This publication has 194 references indexed in Scilit:
- Cancer PrehabilitationAmerican Journal of Physical Medicine & Rehabilitation, 2013
- The Hallmarks of AgingCell, 2013
- Physical and psychosocial benefits of yoga in cancer patients and survivors, a systematic review and meta-analysis of randomized controlled trialsBMC Cancer, 2012
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to ChemotherapyScience Translational Medicine, 2012
- Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database studyBritish Journal of Cancer, 2011
- Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401Journal of Clinical Oncology, 2011
- Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and TelomeresAnnals of the New York Academy of Sciences, 2009
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Effects of Home-Based Diet and Exercise on Functional Outcomes Among Older, Overweight Long-term Cancer SurvivorsJAMA, 2009
- Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapyProceedings of the National Academy of Sciences of the United States of America, 2008